Literature DB >> 7721078

Human mast cell heterogeneity.

A M Irani1, L B Schwartz.   

Abstract

Mast cell neutral proteases are the most precise markers of heterogeneity among human mast cells. Two types of human mast cells have been recognized. MCTC cells contain tryptase together with chymase, cathepsin-G like protease, and mast cell carboxypeptidase; MCT cells contain tryptase, but lack the other neutral proteases present in MCTC cells. All mast cells develop from hemopoietic stem cells. In vitro procedures for studying mast cell growth have been developed, using the major human mast cell growth factor, stem cell factor (SCF, also called Kit-ligand). Cultures of hemopoietic progenitor cells in the presence of SCF alone result in selective differentiation to mast cells. The same progenitor cells can be induced to differentiate into other lineages when SCF is used with various lineage-specific colony-stimulating factors such as erythropoietin for erythrocytes. Mast cell development from hematopoietic progenitors may represent a "default pathway," occurring optimally in a permissive microenvironment such as skin, bowel, and lung. The presence or absence of certain cytokines in blood and bone marrow may create a non-permissive environment, thus the absence of granulated mast cells in such locations.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7721078     DOI: 10.2500/108854194778816472

Source DB:  PubMed          Journal:  Allergy Proc        ISSN: 1046-9354


  27 in total

1.  Mastocytosis: the great masquerader.

Authors:  James S W Kong; Suzanne Teuber; Rosemary Hallett; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2006-02       Impact factor: 8.667

2.  Phagocytic and tumor necrosis factor alpha response of human mast cells following exposure to gram-negative and gram-positive bacteria.

Authors:  M Arock; E Ross; R Lai-Kuen; G Averlant; Z Gao; S N Abraham
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

3.  Discovery to Launch of Anti-allergy (Emadine; Patanol/Pataday/Pazeo) and Anti-glaucoma (Travatan; Simbrinza) Ocular Drugs, and Generation of Novel Pharmacological Tools Such as AL-8810.

Authors:  Najam A Sharif
Journal:  ACS Pharmacol Transl Sci       Date:  2020-11-05

Review 4.  Tissue-specific expression of mast cell granule serine proteinases and their role in inflammation in the lung and gut.

Authors:  Hugh R P Miller; Alan D Pemberton
Journal:  Immunology       Date:  2002-04       Impact factor: 7.397

5.  Usefulness of serum mast cell-specific chymase levels for postmortem diagnosis of anaphylaxis.

Authors:  Hajime Nishio; Shinji Takai; Mizuo Miyazaki; Hidekazu Horiuchi; Motoki Osawa; Koichi Uemura; Ken-ichi Yoshida; Masahiro Mukaida; Yasuhiro Ueno; Koichi Suzuki
Journal:  Int J Legal Med       Date:  2005-02-26       Impact factor: 2.686

Review 6.  Mast cell biology: introduction and overview.

Authors:  Alasdair M Gilfillan; Sarah J Austin; Dean D Metcalfe
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

7.  Novel six-week protocol for generating functional human connective tissue-type (MCTC) mast cells from buffy coats.

Authors:  Issan Yee San Tam; Chun Wai Ng; See-Ying Tam; Hang Yung Alaster Lau
Journal:  Inflamm Res       Date:  2016-09-15       Impact factor: 4.575

8.  Mast cells in the amphibian brain during development.

Authors:  Claudia Pinelli; Alessandra Santillo; Gabriella Chieffi Baccari; Rossella Monteforte; Rakesh K Rastogi
Journal:  J Anat       Date:  2010-01-07       Impact factor: 2.610

Review 9.  Possible biological and translational significance of mast cells density in colorectal cancer.

Authors:  Ilaria Marech; Michele Ammendola; Claudia Gadaleta; Nicola Zizzo; Caroline Oakley; Cosmo Damiano Gadaleta; Girolamo Ranieri
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

10.  Histamine is not released in acute thermal injury in human skin in vivo: a microdialysis study.

Authors:  Lars J Petersen; Juri L Pedersen; Per S Skov; Hans J Nielsen; Henrik Kehlet
Journal:  Inflamm Res       Date:  2009-03-06       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.